Day: November 12, 2021

Alcanna Reports Third Quarter Financial Results

Alcanna Reports Third Quarter Financial Results

EDMONTON, Alberta, Nov. 12, 2021 (GLOBE NEWSWIRE) — Alcanna Inc. (the “Company” or “Alcanna”) (TSX: CLIQ) today reported its financial results for the three and nine months ended September 30, 2021.   Third Quarter Financial Results For the third quarter of 2021, Alcanna’s same-store liquor sales from continuing operations was $145.4 million, 5.1% lower than Q3 2020 but an increase of 7.1% from Q3 2019. The operating profit before depreciation, remeasurements and provisions for the Company’s Liquor and Corporate Segments for the three months ended September 30, 2021 was $10.4 million compared to $13.9 million in Q3 2020 and $7.2 million for Q3 2019. The Company’s condensed interim consolidated financial statements and management’s discussion and analysis (“MDA”) for the three and nine months ended September 30, 2021 will be...

Continue reading

Northview Canadian High Yield Residential Fund Announces Q3 2021 Financial Results and Executive Team Changes

Northview Canadian High Yield Residential Fund Announces Q3 2021 Financial Results and Executive Team Changes

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) — Northview Canadian High Yield Residential Fund (“Northview” or the “Fund”) (NHF.UN – TSX), today announced financial results for the three and nine months ended September 30, 2021. All amounts in this news release are in thousands of Canadian dollars unless otherwise indicated.         “We are pleased to report another quarter of stable financial performance with an FFO payout ratio of 70.7%,” commented Mr. Todd Cook, Northview’s Chief Executive Officer. “The Northview team continues to focus its efforts and commitment on the safety of our residents, tenants, employees, and business partners, which was paramount as we experienced the fourth wave of COVID-19. The impact of the...

Continue reading

Urbana Corporation Has Filed September 30, 2021 Interim Financial Statements

Urbana Corporation Has Filed September 30, 2021 Interim Financial Statements

/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) — Urbana Corporation (TSX & CSE: URB & URB.A) Urbana Corporation announces today that it has filed its unaudited Interim Financial Statements and Management’s Discussion and Analysis for the nine-month period ended September 30, 2021 with the applicable Canadian securities regulators. PDF versions of the documents are available at www.urbanacorp.com and at www.sedar.com. For further information contact:Elizabeth NaumovskiInvestor Relations(416) 595-9106 enaumovski@urbanacorp.com

Continue reading

Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference Mont-Saint-Guibert, Belgium. – November 12, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference on from November 22 to December 2, 2021. A webcast of the Company’s fireside chat will be available on the Company’s investor relations website at https://investors.nyxoah.com/ Nyxoah is participating in investor 1×1 meetings, which can be requested through Piper Sandler. About NyxoahNyxoah is a medical technology...

Continue reading

D2L ANNOUNCES PARTICIPATION AT UPCOMING INVESTOR CONFERENCES

D2L ANNOUNCES PARTICIPATION AT UPCOMING INVESTOR CONFERENCES

Toronto, Nov. 12, 2021 (GLOBE NEWSWIRE) — D2L Inc. (TSX: DTOL), a global learning technology leader, announced today participation in the following investor conferences: TD Securities Virtual Technology Conference: John Baker, President and CEO, and Melissa Howatson, Chief Financial Officer, will participate in an interactive virtual discussion on Monday, November 15, 2021, at 10:25 am ET. A live video webcast of the discussion will be available under the investor relations section of D2L’s website at ir.d2l.com/events-and-presentations/events/. KeyBanc Capital Markets Sector Spotlight: Education Technology: Mr. Baker will also be participating in a panel discussion at the KeyBanc EdTech Private Event on November 16, 2021. ABOUT D2L (TSX: DTOL) D2L is transforming the way the world learns—helping learners of all ages achieve...

Continue reading

Interpublic Group to Present at the Morgan Stanley European Technology, Media and Telecom Conference

Interpublic Group to Present at the Morgan Stanley European Technology, Media and Telecom Conference

New York, NY, Nov. 12, 2021 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) senior management will present at the Morgan Stanley European Technology, Media & Telecom Conference on Wednesday, November 17th 2021, at 1:15 pm Eastern time, as scheduled. A link to the live webcast will be posted on the day of the conference on the Investor Relations section of Interpublic’s website (http://investors.interpublic.com) where it will remain available for replay for 30 days. # # # About InterpublicInterpublic (NYSE: IPG) (www.interpublic.com) is a values-based, data-fueled, and creatively-driven provider of marketing solutions. Home to some of the world’s best-known and most innovative communications specialists, IPG global brands include: Acxiom, Craft, FCB, FutureBrand, Golin, Huge, Initiative, Jack Morton, Kinesso, MAGNA,...

Continue reading

Phathom Pharmaceuticals to Participate in Two Upcoming Investor Healthcare Conferences

Phathom Pharmaceuticals to Participate in Two Upcoming Investor Healthcare Conferences

FLORHAM PARK, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of its management team will participate at two upcoming virtual investor conferences, including: Guggenheim Healthcare Talks: 3rd Annual Neuro/Immunology ConferenceDate: November 16, 2021Live Webcast: 9:40 am EST Jefferies London Healthcare ConferenceDate: November 17, 2021Fireside Chat: 5:00 am EST / 10:00 am GMT Members of Phathom’s management team will also participate virtually in one-on-one meetings throughout the duration of each conference. To access the live webcast and archived recording of the presentations, visit the News & Events section of the Phathom...

Continue reading

Prudential Bancorp, Inc. Announces Fiscal 2021 Results

Prudential Bancorp, Inc. Announces Fiscal 2021 Results

PHILADELPHIA, Nov. 12, 2021 (GLOBE NEWSWIRE) — Prudential Bancorp, Inc. (the “Company”) (Nasdaq:PBIP), the holding company for Prudential Bank (the “Bank”), reported net income of $2.0 million, or $0.26 per basic and $0.25 per diluted share, for the quarter ended September 30, 2021 as compared to $548,000, or $0.07 per basic and diluted share, for the same quarter in fiscal 2020. For the fiscal year ended September 30, 2021, the Company reported net income of $7.8 million, or $0.98 per basic and diluted share as compared to $9.6 million, or $1.12 per basic and diluted share, for fiscal 2020. Fiscal year 2020 included significant gains on sales of investment securities available for sale. Dennis Pollack, President and CEO, commented, “We are pleased to report improvement in both our net interest margin and interest rate spread,...

Continue reading

Atlanticus Reports Third Quarter 2021 Financial Results

Atlanticus Reports Third Quarter 2021 Financial Results

Net Income Attributable to Common Shareholders Increases to $40.3 Million, or $1.96 per Share ATLANTA, Nov. 12, 2021 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company which enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced its financial results for the third quarter ended September 30, 2021. Financial and Operating Highlights 2021 Third Quarter compared to 2020 Third Quarter Total operating revenue increased 41.8% to $203.9 million. Purchase volume increased 55.7% to $610.5 million. The number of total customers we serve(1) increased 59.8% to 2.6 million. Since the start of the third quarter 2021, customers served increased by over 388,000,...

Continue reading

Quotient Limited to Participate in the Jefferies London Healthcare Conference

Quotient Limited to Participate in the Jefferies London Healthcare Conference

JERSEY, Channel Islands, Nov. 12, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the management team will present at the Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 8:40am GMT (3:40am ET). A webcast of the presentation will be available online from the investor relations page of the Company’s corporate website at www.quotientbd.com. A webcast replay will be archived on the website for approximately 90 days. About Quotient Limited Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.